Bupropion/Trazodone

安非他酮/曲唑酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBupropion/Trazodone
Drug Alias NameBupropion+Trazodone安非他酮-曲唑酮安非他酮•曲唑酮Bupropion-TrazodoneBupropion•Trazodone +[16
ClassificationSmall molecules
Mechanisms of ActionSerotonin transporter inhibitorsSerotonin reuptake inhibitorsAdrenergic receptors antagonists +[4
TargetsSerotonin transporterAdrenergic receptorsDopamine transporter
Therapy Area/IndicationsSexual Dysfunctions, Psychological
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesS1 Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesS1 Biopharma Inc
Inactive CompaniesN/A
Active IndicationsSexual Dysfunctions, Psychological
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A